You did what you were supposed to do. You asked for help. You tried medication. You went to therapy. And the depression is still there. Maybe it lifted slightly and then settled back in. Maybe it never responded at all. Maybe you have been through two or three or five different antidepressants and the side effects changed but the depression did not.
If this is your experience, you are not failing at recovery. You may be dealing with treatment-resistant depression, a clinical designation that applies when standard treatments have not produced adequate relief. Research published in the Journal of Clinical Psychiatry estimates that 10 to 30 percent of people with depression fall into this category. That is a significant number, and if you are in it, the most important thing to understand is that “treatment-resistant” does not mean “untreatable.” It means the first approaches did not work, and the search for what will work needs to continue.
What Treatment-Resistant Depression Means
There is no single, universally agreed-upon definition, but the general clinical standard is that depression is considered treatment-resistant when it has not responded adequately to at least two different antidepressant trials at appropriate doses for appropriate durations. “Appropriate” is doing important work in that sentence, because one of the most common reasons depression appears resistant is that the previous treatments were not actually given a fair chance.
Medication may have been prescribed at too low a dose. It may not have been taken consistently. The trial period may have been too short, since most antidepressants require six to eight weeks at a therapeutic dose before effectiveness can be evaluated. A co-occurring condition, such as anxiety, a thyroid disorder, chronic pain, or substance use, may be interfering with the medication’s effectiveness. Or the specific medication may have been a poor match for your particular neurochemistry, which is information you could not have had in advance.
Before concluding that your depression is truly resistant to treatment, it is worth working with a medical professional to rule out these factors. A thorough review of your treatment history, your medication adherence, your physical health, and any interactions between medications you are taking can reveal treatable obstacles that were not previously identified.
Adjusting the Medication Approach
If the standard medication approach has genuinely failed, there are several pharmacological options that your prescriber can explore. Dosage adjustment is the simplest: some people require doses at the higher end of the therapeutic range to achieve a response. Switching to a different class of antidepressant can be effective when one class has not worked, because different medications target different neurotransmitter systems and your brain may respond better to one mechanism than another.
Augmentation strategies involve adding a second medication to enhance the effect of the first. This might mean combining two antidepressants that work through different pathways, or adding a medication from a different class entirely, such as a mood stabilizer or an atypical antipsychotic, to boost the antidepressant’s effectiveness.
Pharmacogenetic testing is an increasingly available option that analyzes how your body metabolizes specific medications based on your genetic profile. This can provide guidance about which medications are most likely to be effective for you and which are likely to produce side effects, reducing the trial-and-error process that makes medication management so frustrating.
All medication decisions should be made in close collaboration with your prescriber. The information here is not a substitute for that conversation. It is context to help you have it more productively.
Why Therapy Still Matters, Especially Now
If medication has not resolved your depression, you might reasonably wonder whether therapy will be any different. The answer is that therapy and medication work through fundamentally different mechanisms, and the failure of one does not predict the failure of the other.
Medication addresses the neurochemical dimension of depression. Therapy addresses the psychological, behavioral, and relational dimensions: the thought patterns that maintain the depressive state, the coping strategies that may be inadvertently reinforcing it, the unresolved experiences that may be fueling it, and the behavioral withdrawal that deepens it.
For treatment-resistant depression specifically, several therapeutic approaches have strong evidence. Cognitive Behavioral Therapy (CBT) helps identify and restructure the distorted thinking patterns that depression produces and maintains. Dialectical Behavior Therapy (DBT) builds skills in emotional regulation, distress tolerance, and mindfulness that directly counteract the emotional flatness and reactivity that characterize persistent depression. EMDR therapy can be particularly valuable when the depression is rooted in or maintained by unresolved trauma, which is more common than many people realize. Processing the traumatic material can unlock a depression that medication alone could not reach because the depression was a trauma response, not purely a neurochemical imbalance.
Therapy also provides something medication cannot: a relationship with another human being who is attuned to your experience, who helps you make sense of what you are going through, and who witnesses your struggle without judgment. For someone who has been fighting depression for years without relief, the therapeutic relationship itself can be a source of genuine healing.
Advanced Treatment Options
When both medication and therapy have been tried and the depression persists, additional interventions may be worth exploring with your treatment team.
Repetitive Transcranial Magnetic Stimulation (rTMS) uses targeted magnetic fields to stimulate specific areas of the brain involved in mood regulation. It is non-invasive, does not require anesthesia, and has been FDA-approved for treatment-resistant depression since 2008. Treatment typically involves daily sessions over several weeks, and many patients experience meaningful improvement.
Ketamine and esketamine represent one of the more significant developments in depression treatment in recent decades. Unlike traditional antidepressants, which can take weeks to produce effects, ketamine can provide rapid relief, sometimes within hours. Esketamine (Spravato) is an FDA-approved nasal spray administered in supervised clinical settings. These treatments are typically reserved for cases where other approaches have failed, and they require careful medical oversight.
Vagus Nerve Stimulation (VNS) uses an implanted device to send mild electrical impulses to the brain through the vagus nerve. It is generally considered when multiple other treatments have been unsuccessful.
These options are not first-line treatments, and they are not available through a therapy practice. They require referral to specialized medical providers. But knowing they exist is important, because it means the treatment landscape extends well beyond the approaches that have already been tried.
The Lifestyle Dimension
When you are in the depths of treatment-resistant depression, being told to exercise and eat well can feel dismissive. You are aware that these things help. You are also aware that the depression is making it nearly impossible to do them. That tension is real and it should be acknowledged.
At the same time, lifestyle factors genuinely affect the neurochemistry that depression operates on, and they can either support or undermine whatever other treatment you are receiving. Regular physical activity produces changes in brain chemistry that are measurably antidepressant. Consistent sleep supports the neural processes that regulate mood. Alcohol and recreational drugs, which many people use to cope with persistent depression, reliably worsen the condition over time even when they provide temporary relief.
The approach that works for treatment-resistant depression is not “just exercise more.” It is building small, sustainable changes into your daily life with the support of a therapist who understands that your executive functioning is impaired and that motivation is one of the things the depression has taken from you. Behavioral activation, a specific CBT-based approach, works by scheduling small, manageable activities and building from there, rather than waiting for motivation to arrive. The activity produces the motivation, not the other way around. We wrote more about this approach in our post on managing depression without medication.
Depression Therapy in Lakewood and Longmont, Colorado
At Self Care Impact Counseling, we work with individuals managing depression at every level of severity, including those who have tried other treatments without adequate relief. Our therapists in Lakewood and Longmont use CBT, DBT, EMDR, and other evidence-based approaches, and we collaborate with prescribers and medical providers when a coordinated treatment approach is needed. We offer both in-person and online sessions for anyone in Colorado.
We invite you to call us at 720-551-4553 for a free 20-minute phone consultation, or try our Find-Your-Therapist tool to get matched with a therapist who fits your needs. You can also reach us through the contact page on our website.
If you or someone you know is in crisis, the 988 Suicide and Crisis Lifeline is available 24/7 by calling or texting 988.
Self Care Impact Counseling envisions a new age of counseling for adolescents, adults, couples and groups that makes a REAL difference with core values of GROWTH | BALANCE | COMPASSION | INNER HARMONY.
About the Author
Alayna Baillod, LCSW, is a Clinical Supervisor and the Owner of Self Care Impact Counseling. She is an EMDRIA Approved EMDR Consultant and EMDR Therapist, extensively trained in Gottman Couples Therapy, Emotion-Focused Therapy (EFT), DBT, Somatic Therapy, Internal Family Systems (IFS), and Attachment Theory. Alayna specializes in couples counseling, EMDR trauma therapy, and codependency recovery. Find your therapist here.
